Key result
The platelet function analyser (PFA-100) and single-platelet counting provide accessible and physiologically relevant approaches for assessing platelet aggregation in whole blood.
PFA-100 and single-platelet counting offer accessible, physiologically relevant methods for assessing platelet aggregation in whole blood compared to traditional specialized laboratory techniques.
May offer practical platelet testing options; leaves open validation for clinical use.
Platelets play a crucial role in haemostasis and thrombosis and evaluation of platelet function in vitro, in particular platelet aggregation responses, has been one of the most common and useful ways of evaluating the risk of bleeding and thrombotic events and assessing the effects of various compounds and conditions on platelets. Traditional approaches to assessing platelet aggregation require specialised equipment and trained laboratory personnel and have other limitations. Studying platelet aggregation in whole blood offers a more physiologically relevant measurement. Additionally, certain approaches could be more widely available than in specialised laboratories. Here we summarise the application of the platelet function analyser (PFA-100), an accessible first point-of-care test for platelet function in whole blood, and the less established, but promising approach of assessing platelet aggregation by single-platelet counting that can also be performed in whole blood. The possibilities of a wider and more accessible application of the latter methodology are also discussed.
No takes yet. Share an insight, caveat, or question.
Dovlatova et al. (2018) reported a review. Platelet function analyser (PFA-100) and single-platelet counting was evaluated. The platelet function analyser (PFA-100) and single-platelet counting provide accessible and physiologically relevant approaches for assessing platelet aggregation in whole blood.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: